Hambrecht & Quist Capital Management as of March 31, 2012
Portfolio Holdings for Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management holds 73 positions in its portfolio as reported in the March 2012 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 5.0 | $29M | 588k | 48.85 | |
Teva Pharmaceutical Industries (TEVA) | 4.8 | $28M | 612k | 45.06 | |
Alexion Pharmaceuticals | 4.8 | $27M | 293k | 92.86 | |
Celgene Corporation | 4.1 | $23M | 298k | 77.52 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.6 | $21M | 499k | 41.01 | |
Perrigo Company | 3.3 | $19M | 182k | 103.31 | |
Mylan | 3.2 | $18M | 781k | 23.45 | |
Akorn | 3.0 | $17M | 1.5M | 11.70 | |
Regeneron Pharmaceuticals (REGN) | 2.8 | $16M | 138k | 116.62 | |
Aetna | 2.3 | $13M | 256k | 50.16 | |
Impax Laboratories | 2.3 | $13M | 524k | 24.58 | |
Biogen Idec (BIIB) | 2.2 | $13M | 100k | 125.97 | |
Medivation | 2.2 | $12M | 166k | 74.72 | |
Allergan | 2.1 | $12M | 123k | 95.43 | |
Shire | 2.0 | $11M | 121k | 94.75 | |
Warner Chilcott Plc - | 2.0 | $11M | 676k | 16.81 | |
Amarin Corporation (AMRN) | 2.0 | $11M | 1.0M | 11.32 | |
Alere | 1.9 | $11M | 422k | 26.01 | |
Express Scripts | 1.9 | $11M | 199k | 54.18 | |
United Therapeutics Corporation (UTHR) | 1.8 | $10M | 219k | 47.13 | |
Merck & Co (MRK) | 1.7 | $9.9M | 258k | 38.40 | |
PerkinElmer (RVTY) | 1.7 | $9.6M | 346k | 27.66 | |
Quest Diagnostics Incorporated (DGX) | 1.6 | $9.0M | 148k | 61.15 | |
Gen-Probe Incorporated | 1.6 | $9.0M | 136k | 66.41 | |
Thermo Fisher Scientific (TMO) | 1.6 | $8.8M | 157k | 56.38 | |
Verastem | 1.5 | $8.7M | 885k | 9.84 | |
Cubist Pharmaceuticals | 1.5 | $8.6M | 199k | 43.25 | |
PAREXEL International Corporation | 1.4 | $8.2M | 303k | 26.97 | |
Watson Pharmaceuticals | 1.4 | $8.2M | 122k | 67.06 | |
Vivus | 1.4 | $8.1M | 361k | 22.36 | |
Nektar Therapeutics (NKTR) | 1.4 | $8.0M | 1.0M | 7.92 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.4 | $8.0M | 65k | 123.30 | |
Life Technologies | 1.2 | $6.7M | 138k | 48.82 | |
Covance | 1.2 | $6.7M | 140k | 47.63 | |
Neurocrine Biosciences (NBIX) | 1.1 | $6.5M | 813k | 7.97 | |
Alkermes (ALKS) | 1.1 | $6.4M | 346k | 18.55 | |
Baxter International (BAX) | 1.1 | $6.3M | 105k | 59.78 | |
Amgen (AMGN) | 1.1 | $6.2M | 92k | 67.99 | |
Onyx Pharmaceuticals | 1.1 | $6.2M | 164k | 37.68 | |
Ceres | 1.1 | $6.2M | 428k | 14.39 | |
Human Genome Sciences | 1.0 | $5.9M | 719k | 8.24 | |
UnitedHealth (UNH) | 1.0 | $5.6M | 94k | 58.94 | |
Dendreon Corporation | 0.9 | $5.4M | 506k | 10.65 | |
Elan Corporation | 0.9 | $5.4M | 357k | 15.01 | |
Illumina (ILMN) | 0.9 | $5.3M | 101k | 52.61 | |
Ariad Pharmaceuticals | 0.9 | $5.1M | 322k | 15.95 | |
McKesson Corporation (MCK) | 0.9 | $5.0M | 57k | 87.77 | |
IDEXX Laboratories (IDXX) | 0.9 | $4.9M | 56k | 87.44 | |
Intellipharmaceuticsintl Inc C | 0.9 | $4.9M | 1.7M | 2.82 | |
Bruker Corporation (BRKR) | 0.8 | $4.8M | 317k | 15.31 | |
CVS Caremark Corporation (CVS) | 0.8 | $4.7M | 106k | 44.80 | |
Endo Pharmaceuticals | 0.6 | $3.4M | 89k | 38.73 | |
Santarus | 0.5 | $2.6M | 448k | 5.85 | |
Accuray Incorporated (ARAY) | 0.5 | $2.6M | 365k | 7.06 | |
NPS Pharmaceuticals | 0.4 | $2.1M | 312k | 6.84 | |
Jazz Pharmaceuticals (JAZZ) | 0.3 | $1.9M | 39k | 48.46 | |
Acorda Therapeutics | 0.3 | $1.7M | 63k | 26.55 | |
Addus Homecare Corp (ADUS) | 0.3 | $1.6M | 322k | 4.95 | |
OncoGenex Pharmaceuticals | 0.3 | $1.5M | 113k | 13.29 | |
Hca Holdings (HCA) | 0.3 | $1.5M | 60k | 24.74 | |
Keryx Biopharmaceuticals | 0.2 | $1.4M | 272k | 4.98 | |
Momenta Pharmaceuticals | 0.2 | $1.4M | 89k | 15.32 | |
Community Health Systems (CYH) | 0.2 | $1.2M | 56k | 22.24 | |
Zogenix | 0.2 | $1.3M | 625k | 2.00 | |
LifePoint Hospitals | 0.2 | $1.2M | 31k | 39.43 | |
Aegerion Pharmaceuticals | 0.2 | $1.1M | 81k | 13.83 | |
Palomar Medical Technologies | 0.2 | $1.1M | 113k | 9.34 | |
Targacept | 0.2 | $998k | 195k | 5.12 | |
Cornerstone Therapeutics | 0.2 | $1.0M | 174k | 5.96 | |
Health Management Associates | 0.2 | $925k | 138k | 6.72 | |
Curis | 0.1 | $450k | 93k | 4.82 | |
Sanofi Aventis Wi Conval Rt | 0.0 | $140k | 104k | 1.35 | |
iCAD | 0.0 | $43k | 87k | 0.50 |